Show simple item record

dc.contributor.authorBhalay, G
dc.date.accessioned2021-03-18T11:18:48Z
dc.date.available2021-03-18T11:18:48Z
dc.date.issued2018-08-02
dc.identifierWO 2018138293
dc.identifier.citation2018
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4418
dc.description.abstractThe invention relates to compds. of formula I and pharmaceutically acceptable salts and solvates thereof (wherein X1 and X2 are independently CH and N; p = 1 - 3; each R when present is halo; R0 and R1 are independently H, halo, CN, etc.; R2 and R3 are independently H, C1-​6 alkyl, C3-​10 cycloalkyl, etc.; R4 and R5 are independently H, C1-​6 alkyl, C1-​6 aminoalkyl, etc.; R6 is H, C1-​6 (halo)​alkyl, etc.;) as Rho kinase inhibitors, methods of prepg. such compds., pharmaceutical compns. contg. them and therapeutic use thereof. Particularly the compds. of the invention may be useful in the treatment of many disorders assocd. with ROCK enzymes mechanisms, such as pulmonary diseases including asthma, chronic obstructive pulmonary disease (COPD)​, idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH)​. Example compd. II was prepd. by a multistep procedure (procedure given)​. The invention compds. were evaluated for their ROCK1 and ROCK2 inhibitory activities. From the assay, it was detd. that compd. II exhibited Ki value of < 3 nM.
dc.language.isoeng
dc.titlePreparation of tyrosine amide derivatives as Rho-​kinase inhibitors
dc.typePatent
rioxxterms.versionVoR
rioxxterms.licenseref.startdate2018-08-02
rioxxterms.licenseref.startdate2018-08-02en_US
rioxxterms.typePatent
pubs.noteshttps://patents.google.com/patent/WO2018138293A1/en?oq=WO+2018138293
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Medicinal Chemistry 1
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Medicinal Chemistry 1
pubs.embargo.termsNot known
icr.researchteamMedicinal Chemistry 1
icr.researchteamMedicinal Chemistry 1en_US
dc.contributor.icrauthorBhalay, Gurdipen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record